Literature DB >> 9696699

Effects of Helicobacter pylori gastritis on gastric secretion in healthy human beings.

M Feldman1, B Cryer, E Lee.   

Abstract

Helicobacter pylori gastritis is common, but effects on gastric secretion are not well understood. We measured basal and pentagastrin-stimulated gastric acidity, pepsin activity, and fluid output, as well as serum gastrin concentrations and H. pylori antibody levels, before and after treatment of H. pylori gastritis in 28 men and women. Subjects were studied before and 1 and 3 mo after a course of bismuth, metronidazole, and tetracycline. Elimination of H. pylori gastritis, accomplished in 14 subjects, increased basal and pentagastrin-stimulated gastric acidity (by 15 meq/l) and basal acid output significantly (by 2.1 meq/h 1 mo after therapy). Elimination of H. pylori had an opposite effect on pepsin secretion, significantly decreasing pepsin output by 30%. Elimination of H. pylori significantly reduced nonparietal fluid output by 35%, without affecting fluid output from parietal cells. Serum gastrin and H. pylori antibody levels declined significantly after elimination of H. pylori. None of these changes was observed in 14 subjects whose H. pylori gastritis was resistant to antimicrobial therapy. In summary, eradication of H. pylori infection increases gastric acidity by reducing nonparietal gastric secretion from peptic and other cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9696699     DOI: 10.1152/ajpgi.1998.274.6.G1011

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  14 in total

1.  Inhibitory potency of twice-a-day omeprazole on gastric acidity is enhanced by eradication of H. pylori in duodenal ulcer patients.

Authors:  A B R Thomson; M Keelan; R Lastiwka; S Appelman-Eszczuk; L Zuk; L Drozdowski; A Prentice; P Sinclair
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

2.  Direct measurement of gastric H+/K+-ATPase activities in patients with or without Helicobacter pylori-associated chronic gastritis.

Authors:  Duangporn Thong-Ngam; Pisit Tangkijvanich; Pichet Sampatanukul; Paungpayom Prichakas; Varocha Mahachai; Piyaratana Tosukowong
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

3.  Preoperative nutritional deficiencies in severely obese bariatric candidates are not linked to gastric Helicobacter pylori infection.

Authors:  Rahel Gerig; Barbara Ernst; Britta Wilms; Martin Thurnheer; Bernd Schultes
Journal:  Obes Surg       Date:  2013-05       Impact factor: 4.129

4.  Gastrin and antral G cells in course of Helicobacter pylori eradication: six months follow up study.

Authors:  Aleksandra Sokic-Milutinovic; Vera Todorovic; Tomica Milosavljevic; Marjan Micev; Neda Drndarevic; Olivera Mitrovic
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

5.  Tablet and oral liquid L-thyroxine formulation in the treatment of naïve hypothyroid patients with Helicobacter pylori infection.

Authors:  Danilo Ribichini; Giulia Fiorini; Andrea Repaci; Valentina Castelli; Luigi Gatta; Dino Vaira; Renato Pasquali
Journal:  Endocrine       Date:  2016-11-15       Impact factor: 3.633

6.  Gastric hypochlorhydria is associated with an exacerbation of dyspeptic symptoms in female patients.

Authors:  Wataru Iwai; Yasuhiko Abe; Katsunori Iijima; Tomoyuki Koike; Kaname Uno; Naoki Asano; Akira Imatani; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2012-07-25       Impact factor: 7.527

7.  Gastrin (G) cells and somatostatin (D) cells in patients with dyspeptic symptoms: Helicobacter pylori associated and non-associated gastritis.

Authors:  Y Liu; G D C Vosmaer; G N J Tytgat; S-D Xiao; F J W Ten Kate
Journal:  J Clin Pathol       Date:  2005-09       Impact factor: 3.411

8.  Protective effect of ammonia against reflux esophagitis in rats.

Authors:  H Hamada; K Haruma; M Mihara; T Kamada; K Sumii; G Kajiyama
Journal:  Dig Dis Sci       Date:  2001-05       Impact factor: 3.199

9.  Helicobacter pylori infection affects immune responses following vaccination of typhoid-naive U.S. adults with attenuated Salmonella typhi oral vaccine CVD 908-htrA.

Authors:  Khitam Muhsen; Marcela F Pasetti; Mardi K Reymann; David Y Graham; Myron M Levine
Journal:  J Infect Dis       Date:  2013-11-23       Impact factor: 5.226

Review 10.  Gastrin and the Moderate Hypergastrinemias.

Authors:  Jens F Rehfeld
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.